Yahoo Search Busca da Web

Resultado da Busca

  1. 9 de mai. de 2024 · Hemophilia, hereditary bleeding disorder caused by a deficiency of a substance necessary for blood clotting (coagulation). In hemophilia A, the missing substance is factor VIII. The increased tendency to bleeding usually becomes noticeable early in life and may lead to severe anemia or even death.

    • The Editors of Encyclopaedia Britannica
  2. Há 5 dias · Migration of substantial populations from these high-prevalence areas to low-prevalence countries in Europe has dramatically increased in recent decades and in some European countries, sickle cell disease has now overtaken more familiar genetic conditions such as haemophilia and cystic fibrosis.

  3. 15 de mai. de 2024 · Hemophilia is a bleeding disorder in which blood does not clot properly. Hemophilia A and B are the most common types. Clotting factor tests are used to help diagnose hemophilia. Hemophilia treatment centers are comprehensive clinics that treat people who have bleeding disorders.

  4. 15 de mai. de 2024 · As many as 33,000 males are estimated to be living with hemophilia in the United States. Hemophilia is associated with spontaneous (unexplained) bleeding and excessive bleeding after injury. This can include repeated bleeding within joints that can lead to chronic joint disease. Bleeding symptoms in females with hemophilia are ...

  5. 19 de mai. de 2024 · Dr Roberts examines the latest research in hemophilia A, including standard and EHL factor products, nonfactor products, and gene therapy.

  6. 18 de mai. de 2024 · Pediatric Hemophilia: Diagnosis, Classification, and Management. Accurate classification of disease and appropriate prophylaxis and treatment are essential to prevent serious bleeding-related morbidities, as Drs. Roberts and Monahan explain. Authors: Harold R. Roberts, MD; Paul E. Monahan, MD. Log In to Start. THIS ACTIVITY HAS EXPIRED FOR CREDIT.

  7. 29 de mai. de 2024 · In this summary from ASH 2004, Dr. Jeanne M. Lusher discusses the latest data on the management of classic hemophilia and other coagulopathies.